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Letters to the Editor 
Dear Editor 
The theoretic blood pH evolution secondary to rise of 
alveolar tension of carbon dioxide during apnoea in 
anaesthetized humans 
Apnoeic oxygenation (1) is a technique utilized in 
various procedures (2,3), with CO, accumulation and 
respiratory acidosis as the fundamental limitations of 
this technique. 
A series of 30 adult patients, American Society of 
Anaesthesiologists I-II status, aged between 22-53 
(mean 42.86) years were studied to evaluate the CO, 
rise during experimental apnoea in the absence of 
hypoxemia evaluated by a pulse oxymeter saturation 
(SpO,) over 97%. All patients were programmed to 
elective surgery and anaesthetized with fentanyl 
2-3,ug kg-‘, diazepam 0.1 mg kg - ‘, droperidol 
0.05 mg kg - ’ and etomidate 0.3 mg kg - ‘. Paralysis 
was achieved with IV atracurium 0.5-0.75 mg kg-’ 
and then laryngoscopy and tracheal intubation were 
performed. After intubation, a period of preoxygen- 
ation and controlled mechanical hyperventilation 
(end-tidal CO, tension about 30 mmHg) was per- 
formed. Preoxygenation with a fractional inspired 
oxygen (FlO,) of 1 was done to achieve nitrogen 
washout of lungs, and is defined by a difference equal 
or less than 5% between FlO, and the fractional 
end-tidal oxygen (FEtO,). After this period, the 
mechanical ventilation was suspended and patients 
rested in apnoea (maintained by muscle relaxation) 
during a 10 min period. 
A continuous inspiratory gas flow of 1.5 1 min- ’ 
was fixed during the apnoeic period. The fresh gas 
was composed of 3&31% of oxygen, 63-64% of 
nitrous oxide and 555.3% of isoflurane. To minimize 
the reduction in functional residual capacity (FRC), 
a 7.5 cmH,O CPAP was applied. 
The protocol was accepted by the Hospital Ethical 
Committee and verbal and written acceptances were 
obtained from all patients. 
We fixed as exclusions/endings criteria for security 
reasons: 
(a) SpO, less than 94% in basal state (F10,=0.21) 
or less than 95% during experimental apnoeic 
period; 
(b) 20% elevation from basal values of systolic or 
diastolic blood pressure, or 15% from initial 
values of cardiac rate; 
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(c) Presence of sweating and/or lacrimation during 
the experimental apnoeic period. 
The end-tidal pressure of CO, values (PEtCO,) 
were evaluated (Capnomac Ultima, Datex) at the end 
the period of preoxygenation and hyperventilation 
(PEtCO,‘), and at the first respiration during 
mechanical ventilation after the apnoeic period 
(PEtCO,“). 
We define as derivative parameters: 
(1) Rate of rise of PEtCO, min ~ ’ (RCO,) 
[(PEtCO,” - PEtCO,’ - 6)/9, expressed in 
mmHg min - ‘I; 
(2) Theoretical (without renal compensation and 
avoiding the Christiansen-Douglas-Haldane 
effect) blood pH (pHTh) 6.1 +log 
[24/(0.03 PEtCO,)]. 
The PEtCO,’ values were (mean * SD) 
31.36 f 3.78 mmHg and the PEtCO,” values were 
67.66 f 6.4 mmHg. The rate of rise of PEtCO, 
(RCO,), during the apnoeic period had mean global 
values of 3.36 & 0.53 mmHg min - ‘. In the present 
series, the mean values of PEtCO, during the exper- 
imental period fit a theoretic straight line as functions 
of time and RCO,, expressed by the equation 
PECO,(t+l)=37.36+3.36t, where t is the apnoeic 
time in minutes. 
The pHTh values ranged from 7.50-7.17, and 
followed next expression as a function of time 
and RCO,: pHTh(t+ 1)=6.1 +log [24/(0.03 (37.3+ 
RCO,t))]. These pHTh values are very close to 
measured blood pH values (4). 
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We conclude that pHTh during apnoea in anaes- 
thetized humans is a good parameter to estimate real 
pH and to decide on termination of the apnoeic 
period due to acidosis. 
R. MARTIN-LARRAURI*, L. CALLOL~, M. GUASCH$, 
R. MARRERO*, F. J. CASAS* AND 
F. J. G~MEZ-TERREROS~ 
*Service of Intensive Care Medicine and 
tService of Pneumology 
University Hospital of Aire, Complutense University of 
Madrid, and $Service of Anaesthesia, University 
Hospital ‘Gbmez Ulla’, Madrid, Spain 
17 October 1994 
References 
Frumin MJ, Epstein RM, Cohen G. Apneic oxygenation 
in man. Anesthesiology 1959; 20: 789-798. 
Babinsky MF, Sierra OG, Smith RB et al. Clinical 
application of continuous flow apneic ventilation. Acta 
Anaesthesiol Stand 1985; 29: 750-752. 
Milhaud A, Riboulot M, Gayet H. Disconnecting tests 
and oxygen uptake in the diagnosis of total brain death. 
Ann NV Acad Sci 1978: 315: 241-251. 
Eger FI, Severinghaus JW. The rate of rise of PACO, in 
the apneic anesthetized patient. Anesthesiology 1961; 22: 
419. 
Dear Editor 
Air filtration units 
Warburton et al. (1) have completed a very impor- 
tant study which has demonstrated that yet another 
product being marketed for house mite avoidance, 
has no demonstrable value on aeroallergen levels or 
indeed on symptoms of asthma. Such studies are of 
immense importance in providing objective infor- 
mation on which recommendations can be made to 
patients. At present, far too many house dust mite 
sensitive asthma sufferers are persuaded to buy 
domestic products purporting to reduce aeroallergen 
levels, and the medical profession are unable to 
provide clear cut information on their value or lack 
of it (2). 
In their discussion, Warburton et al. (1) have cast 
some doubt on our low volume personal air sampling 
technique for measuring domestic aeroallergen expo- 
sure. We would accept that there is currently no gold 
standard of actual aeroallergen exposure measure- 
ment. However, we do believe that our technique is 
of significant and proven value. The reason why 
Warburton and colleagues’ air sampling technique 
was unable to show any allergen in two-thirds of the 
samples collected was because they used very high 
volume sampling. This has the effect of cleaning the 
air with the very small quantities of allergen in the air 
being diluted by the vast volume of air sampled. Low 
volume sampling collects the allergen at a rate below 
which it is being generated, and there is infinitely less 
dilution. Furthermore, it is essential to use sonication 
to extract the allergen from the samples. Far from 
this having the effect of not reflecting airborne levels 
as suggested in the discussion of Warburton et al., it 
is far more likely to yield meaningful results, and has 
been validated in relation to sensitization (3). 
Obviously a great deal more work is required to 
optimize sampling techniques, but it would have been 
sensible for Warburton et al. to read our previous 
work in this area which has shown that high volume 
sampling is of limited or no value. 
Notwithstanding these comments, studies of aller- 
gen avoidance techniques are essential if we are to 
make meaningful progress on behalf of the very large 
number of allergic subjects who are desperately 
awaiting advice which might have therapeutic benefit. 
J. 0. WARNER AND J. A. WARNER 
Faculty of Medicine 
Southampton General Hospital 
Southampton, U.K. 
21 November 1994 
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Dear Editor 
Carbon dioxide laser bronchoscopy 
We were interested to read the report by Waller 
et al. (1) of their experiences of using laser broncho- 
scopy in the palliative treatment of 142 patients with 
tracheobronchial tumours. They achieved improve- 
ment in symptoms (predominantly dyspnoea, cough, 
stridor, and haemoptysis) in the great majority of 
their patients, with an acceptable risk of compli- 
cations, using a median of two procedures per patient 
(range l-11) requiring a median of 2 days of post- 
operative inpatient care (range 144) during a mean 
follow-up of 18.3 months. 
The majority of their patients had already been 
treated with external beam radiotherapy (XRT), but 
there is a need to compare endobronchial treatment 
